Clinical Trials List
2022-05-02 - 2027-03-22
Phase III
Not yet recruiting5
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ya-Ping Chen 無
- Chun-Hui Lee 無
- Ya-Ting Hsu 無
- 顏志傑 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Ting-An Lin 無
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Hao-Yuan Wang Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- Yao-Chung Liu Division of Hematology & Oncology
- 蔡淳光 Division of Hematology & Oncology
- Sheng-Hsuan Chien Division of Hematology & Oncology
- Po-Shen Ko Division of Hematology & Oncology
- 陳玟均 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Ming-Hung Tsai 無
- 鄭富銘 無
- Chen-Yuan Lin 無
- Chi-Ching Chen 無
- Yu-Min Liao 無
- Ching-Chan Lin 無
- Tzu-Ting Chen 無
- Che-Hung Lin 無
- Ming-Yu Lien 無
- 王秀慈 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Sheng-chieh Chou 無
- 林耘曲 無
- 柯紀綸 無
- MING YAO 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
914 participants
